Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02255578Phase 3Unknown
Phase 3, open-label trial in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Sheba Medical Center. Primary endpoint: Change in egg quality or ovulation rate after Endobarrier treatment at 2.5 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02255578.